Skip to main content

Omnicell, Inc. (OMCL)

NASDAQ: OMCL · IEX Real-Time Price · USD
167.29 0.19 (0.11%)
Oct 22, 2021 4:00 PM EDT - Market closed
Market Cap7.32B
Revenue (ttm)987.48M
Net Income (ttm)59.73M
Shares Out43.26M
EPS (ttm)1.32
PE Ratio126.35
Forward PE37.59
Dividendn/a
Ex-Dividend Daten/a
Volume163,022
Open166.76
Previous Close167.10
Day's Range165.91 - 168.69
52-Week Range82.01 - 168.69
Beta1.05
AnalystsBuy
Price Target170.11 (+1.7%)
Est. Earnings DateNov 2, 2021

About OMCL

Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides p...

IndustryHealth Care Technology
IPO DateAug 7, 2001
CEORandall Lipps
Employees3,080
Stock ExchangeNASDAQ
Ticker SymbolOMCL
Full Company Profile

Financial Performance

In 2020, Omnicell's revenue was $892.21 million, a decrease of -0.54% compared to the previous year's $897.03 million. Earnings were $32.19 million, a decrease of -47.51%.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for Omnicell stock is "Buy." The 12-month stock price forecast is 170.11, which is an increase of 1.69% from the latest price.

Price Target
$170.11
(1.69% upside)
Analyst Consensus: Buy

News

CNVY vs. OMCL: Which Stock Should Value Investors Buy Now?

CNVY vs. OMCL: Which Stock Is the Better Value Option?

Other symbols:CNVY
1 week ago - Zacks Investment Research

Omnicell to Release Third Quarter 2021 Financial Results on November 2, 2021

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its fi...

1 week ago - Business Wire

Buy 3 Medical Info Systems Stocks to Brave Industry-wide Challenges

Stocks like 10x Genomics Inc. (TXG), Omnicell, Inc. (OMCL) and Inspire Medical Systems, Inc. (INSP) are expected to gain despite pandemic-led disruptions.

Other symbols:INSPTXG
2 weeks ago - Zacks Investment Research

Omnicell (OMCL) Soars 3.4%: Is Further Upside Left in the Stock?

Omnicell (OMCL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t...

2 weeks ago - Zacks Investment Research

Omnicell (OMCL) Soars to 52-Week High, Time to Cash Out?

Omnicell (OMCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

2 weeks ago - Zacks Investment Research

FDS Amplicare Hosts Webinar to Advise Pharmacists on Assisting Customers During Medicare Open Enrollment

FORT WORTH, Texas, Oct. 6, 2021 /PRNewswire/ -- FDS Amplicare, which builds industry-leading SaaS technology solutions that strengthen the health of retail pharmacies and their patients, today announced...

2 weeks ago - PRNewsWire

3 Sectors Looking Up Ahead of Q3 Earnings Despite COVID-19 Woes

There has been notable job gains in automotive, hospitality, retail, social assistance and in professional and business services through the past few months.

Other symbols:ANCPSIGPIJFINPAYC
2 weeks ago - Zacks Investment Research

3 Reasons Growth Investors Will Love Omnicell (OMCL)

Omnicell (OMCL) is well positioned to outperform the market, as it exhibits above-average growth in financials.

3 weeks ago - Zacks Investment Research

CPSI vs. OMCL: Which Stock Is the Better Value Option?

CPSI vs. OMCL: Which Stock Is the Better Value Option?

Other symbols:CPSI
3 weeks ago - Zacks Investment Research

Here's Why You Should Add Omnicell (OMCL) to Your Portfolio

Investors continue to be optimistic about Omnicell (OMCL) on its strategic acquisitions and partnerships supporting each of the three legs of its strategy.

4 weeks ago - Zacks Investment Research

Omnicell (OMCL) New Buyout Expands Patient Engagement Suite

With the FDS Amplicare acquisition, Omnicell (OMCL) is expected to gain from several healthcare trends, banking on its offerings of digital technologies, SaaS solutions, and tech-enabled services.

1 month ago - Zacks Investment Research

Omnicell Completes Acquisition of FDS Amplicare

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Completes Acquisition of FDS Amplicare

1 month ago - Business Wire

Is Omnicell (OMCL) a Solid Growth Stock? 3 Reasons to Think " Yes "

Omnicell (OMCL) is well positioned to outperform the market, as it exhibits above-average growth in financials.

1 month ago - Zacks Investment Research

3 MedTech Sectors Benefiting Despite COVID-19 Resurgence

Here we discuss three major subsectors of MedTech and some of their constituent stocks for which COVID-19 has opened up enormous growth prospects.

Other symbols:CPSIEHCISRGOPCH
1 month ago - Zacks Investment Research

Omnicell (OMCL) Opens New Software Development Center in India

Omnicell's (OMCL) new software development center in Bangalore, India, is expected to bolster the company's cloud-based solutions portfolio.

1 month ago - Zacks Investment Research

Omnicell Grows International Footprint with Opening of Omnicell India Software Development Center

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced it has ...

1 month ago - Business Wire

4 MedTechs to Gain in 2H21 Beating the Delta Variant-Led Dip

Investors can choose to invest in MedTech stocks like VREX, OMCL, STAA, and IDXX that have shown tremendous promise amid the pandemic.

Other symbols:IDXXSTAAVREX
1 month ago - Zacks Investment Research

Omnicell (OMCL) Enhances Medication Management With New Release

Omnicell's (OMCL) Summer 2021 Release offers greater platform deployment options, providing customers better flexibility and improving time to value for strategic initiatives.

1 month ago - Zacks Investment Research

CPSI vs. OMCL: Which Stock Is the Better Value Option?

CPSI vs. OMCL: Which Stock Is the Better Value Option?

Other symbols:CPSI
1 month ago - Zacks Investment Research

Looking for a Growth Stock? 3 Reasons Why Omnicell (OMCL) is a Solid Choice

Omnicell (OMCL) possesses solid growth attributes, which could help it handily outperform the market.

1 month ago - Zacks Investment Research

Here's Why You Should Add Omnicell (OMCL) to Your Portfolio

Omnicell (OMCL) ended the second quarter with better-than-expected results, with the top line registering solid year-over-year growth.

1 month ago - Zacks Investment Research

Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology-Enabled Services with Summer 2021 ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced its lat...

2 months ago - Business Wire

Omnicell (OMCL) Rides on New Buyout, Innovation Amid Pandemic

Omnicell (OMCL) accelerates shift to cloud-based solutions and tech-enabled services through the launches of Omnicell One and Central Pharmacy Dispensing Services.

2 months ago - Zacks Investment Research

Is Omnicell (OMCL) a Solid Growth Stock? 3 Reasons to Think " Yes "

Omnicell (OMCL) possesses solid growth attributes, which could help it handily outperform the market.

2 months ago - Zacks Investment Research

Omnicell (OMCL) Hits 52-Week High, Can the Run Continue?

Omnicell (OMCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

2 months ago - Zacks Investment Research